Alumis Future Growth
Future criteria checks 0/6
Alumis's earnings are forecast to decline at 11.8% per annum while its annual revenue is expected to grow at 97.8% per year. EPS is expected to grow by 31.8% per annum.
Key information
-11.8%
Earnings growth rate
31.8%
EPS growth rate
| Pharmaceuticals earnings growth | 23.9% |
| Revenue growth rate | 97.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -315 | -273 | N/A | 5 |
| 12/31/2025 | N/A | -297 | -248 | -228 | 5 |
| 12/31/2024 | N/A | -275 | -216 | -208 | 5 |
| 9/30/2024 | N/A | -239 | -217 | -214 | N/A |
| 6/30/2024 | N/A | -189 | -167 | -164 | N/A |
| 3/31/2024 | N/A | -169 | -144 | -140 | N/A |
| 12/31/2023 | N/A | -155 | -134 | -130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALMS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALMS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALMS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALMS is forecast to have no revenue next year.
High Growth Revenue: ALMS is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALMS's Return on Equity is forecast to be high in 3 years time